Navigation Links
Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
Date:8/7/2008

MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced that 96-week data from the HEAT study show that once-daily EPZICOM (abacavir + lamivudine) provides comparable efficacy to once-daily Truvada(R) (tenofovir DF + emtricitabine) as a first-line option for the treatment of HIV. The data were presented today at the 17th International AIDS Conference in Mexico City, Mexico.

HEAT is the first large, prospective, long-term, head-to-head trial to evaluate the safety and efficacy of EPZICOM and Truvada both combined with a boosted protease inhibitor (Kaletra) administered once-daily in adults who had no previous exposure to HIV medicines. The study involved 688 HIV therapy-naive patients: 343 randomized to treatment with EPZICOM and 345 randomized to treatment with Truvada.

Results of the study found that through 96 weeks efficacy endpoints for EPZICOM were comparable to Truvada, regardless of baseline viral load. At 96 weeks 60% of subjects receiving EPZICOM versus 58% of subjects receiving Truvada achieved a viral load <50 c/mL. Patients receiving EPZICOM also experienced similar median CD4+ cell increases to those patients receiving Truvada, 250 vs. 247. Overall, both regimens were generally well-tolerated with comparable safety profiles and few study discontinuations due to adverse events (6% for both treatment arms). Virologic failure occurred in 14% of patients for both groups.

"The result of the HEAT trial further demonstrates that EPZICOM is an effective first-line option for treatment-naive HIV patients with a well-established safety profile," said John Pottage, M.D., Vice President Global Clinical Development at GlaxoSmithKline. "This study provides the first, head-to-head, completed study comparing these two HIV treatments and demonstrates comparable results between the two."

Additionally, a review of two important inflammatory biomarkers, hs-CRP and IL-6, in the HEAT data set showed that le
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
2. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
3. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
4. Study sees need for standardized evaluation of antibody response to HIV-1
5. Study Links Agent Orange to Prostate Cancer in Vietnam Vets
6. KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults
7. Alcohol consumption declining, according to results of new study
8. UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies
9. Study: verbal aggression may affect childrens behavior
10. Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought
11. First national study of diving-related injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... who treat patients with a severe and progressive ... agonizing treatment decision. , The drug sirolimus can ... shortness of breath. But some patients eventually may ... fatal complications following transplantation. , "It,s a terrible ... of Loyola University Medical Center,s LAM Clinic and ...
(Date:4/17/2014)... of Medicine (BUSM) have discovered that the anti-seizure ... model. The findings, reported in the American ... lead to more effective treatments for alcoholism. , ... leading causes of illness and death in the ... limiting the productivity of workers and necessitating huge ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... risk from thiazolidinedione use, study indicates , MONDAY, Feb. ... as thiazolidinediones, which include Avandia and Actos, are at a ... Women who took a thiazolidinedione drug for a year were ... patients who didn,t take the drug, the researchers found. Women ...
... ... Preserve Liquidity -, , QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ ... cancer diagnostic tests and delivering laboratory services, today announced changes to ... will be comprised of two business segments: (1) administrative headquarters in ...
... ... electrical stimulation device to their training regimen. , ... San Diego, CA (PRWEB) February 17, 2010 -- ... Team presented by Kenda– a US Continental pro men’s cycling team which competes at ...
... ... turnarounds and improving hospital profitability joins StatCom in a strategic partnership program that helps hospitals ... ... Tom Brunelle FACHE, MBA, to the StatCom team. Previously Brunelle served as EVP and CEO ...
... Facelift surgery, ... is becoming more popular than ever in the battle to slow the progression of facial ... , ... February 15, 2010 – Facelift surgery is the second most popular cosmetic surgical ...
... , SALT LAKE CITY , ... (AAPC) announced its 2010 National Conference being held at the Gaylord Opryland ... event draws thousands of attendees including doctors, medical coders and office/practice managers ... the first time this conference has been approved for 15.75 (CME) ...
Cached Medicine News:Health News:Diabetes Drugs Avandia, Actos Tied to Fractures in Women 2Health News:DiagnoCure announces optimization of entreprise structure 2Health News:DiagnoCure announces optimization of entreprise structure 3Health News:DiagnoCure announces optimization of entreprise structure 4Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 2Health News:Compex , Leaders in Electronic Muscle Stimulators, Sponsors the Jelly Belly Cycling Team Presented by Kenda 3Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 2Health News:Tom Brunelle Joins StatCom as Enterprise VP, Northeast Region 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 2Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 3Health News:Who Needs a Facelift? Plastic Surgeon Dr. Robert Zubowski With the Facts 4Health News:AAPC to Host 18th Annual National Conference in Nashville 2Health News:AAPC to Host 18th Annual National Conference in Nashville 3
(Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... Jan. 14, 2014   Oligomerix, Inc. , a privately held ... Alzheimer,s disease (AD) and related neurodegenerative disorders, announced today ... Valhalla, NY as of January 15, 2014 ... New York Medical College. Oligomerix, which is ...
Breaking Medicine Technology:Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... , ... a new market research report is available in its ... Market Review , http://www.reportlinker.com/p0164247/Insulin-Pumps-External---A-World-Market-Review.html , Insulin ... better control over diabetes, when compared to other forms ...
... , BELLEVUE, Wash., Dec. 1 ... retailer of health, beauty, vision, and pharmacy products, today announced ... orders were the highest in company history. This holiday season ... featured more special offers than in previous years and their ...
Cached Medicine Technology:Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: